Get More Involved
SIG Membership is open to all ASRA members. There is no cost to join.
To join, login to your profile here and select your current membership in the lower left. From here, select “Add/Remove Sections” at the bottom of the page.
We’re looking for your suggestions and ideas! Share your feedback at PainSUDSIG@asra.com.
Edify members of ASRA about the underlying causes and treatment of substance use disorders (opioid, alcohol, tobacco, and others), specifically in the context of treating pain in both acute and chronic settings. We seek also to improve access to medication-assisted treatment for opioid use disorder by educating clinical pain practitioners about the need for this important tool in patient care. In this vein, we intend to both pass on existing knowledge and literature about the use of buprenorphine both perioperatively and for chronic pain and to encourage further studies in this regard.
Goals and Objectives
- Educate the ASRA membership about the pathophysiology and treatment of substance use disorders.
- Identify appropriate strategies for improving patient access to medication-assisted treatment for tobacco, alcohol, and opioid use disorders (and other use disorders) in the chronic pain population.
- Encourage and provide assistance for interested pain clinicians to become trained in buprenorphine/methadone/naltrexone treatment as a bridge to formal addiction treatment for patients with opioid use disorder.
- Assist providers with guidance about how to treat pain in patients with active substance use disorders or those in remission.
- Evaluate opportunities to collaborate with other societies, including the American Society of Addiction Medicine, to spread knowledge about SUD treatment to pain providers and treatment of pain to SUD providers.
Check out our other SIGs